HER2 Testing and Correlation With Efficacy of Trastuzumab Therapy
November 1st 2002As a result of the availability and clinical efficacy of trastuzumab (Herceptin), clinicians are now faced with a dilemma regarding the accurate identification of patients with HER2 overexpression. In the October 2002 issue of ONCOLOGY,